Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

Moderna said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot for the virus in a late-stage trial. The positive data pave the way for Moderna ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

Health experts were shocked to see that thimerosal, a preservative that has largely been phased out of U.S. vaccines, was on ...

Moderna disclosed that a study of 56,000 volunteers older than 50 found that its new mRNA influenza vaccine was 27% more effective than an existing influenza shot. That would mean that it is more ...

Used in very low amounts, thimerosal has been used since the 1930s to prevent contamination in multidose vaccine vials, and ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

The CDC's newly rebuilt Advisory Committee on Immunization Practices (ACIP) took aim Thursday at a mercury-based preservative long targeted by vaccine skeptics, recommending that children, pregnant ...